{"id":"https://openalex.org/W4394888069","doi":"https://doi.org/10.3389/fimmu.2024.1377014","title":"High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection","display_name":"High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection","publication_year":2024,"publication_date":"2024-04-17","ids":{"openalex":"https://openalex.org/W4394888069","doi":"https://doi.org/10.3389/fimmu.2024.1377014","pmid":"https://pubmed.ncbi.nlm.nih.gov/38694512","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11061453"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2024.1377014","doi":"https://doi.org/10.3389/fimmu.2024.1377014","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2024.1377014","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1377014/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1377014/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023066502","display_name":"Hitoshi Kawasuji","orcid":"https://orcid.org/0000-0002-5536-101X","observed_orcids":["https://orcid.org/0000-0002-5536-101X"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Kawasuji","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023085962","display_name":"Yoshitomo Morinaga","orcid":"https://orcid.org/0000-0002-3827-6411","observed_orcids":["https://orcid.org/0000-0002-3827-6411"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshitomo Morinaga","raw_affiliation_strings":["Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kentaro Nagaoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kentaro Nagaoka","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057079653","display_name":"Hideki Tani","orcid":"https://orcid.org/0000-0002-6309-277X","observed_orcids":["https://orcid.org/0000-0002-6309-277X","https://orcid.org/0000-0002-8411-7403"]},"institutions":[{"id":"https://openalex.org/I4210090866","display_name":"Toyama Institute of Health","ror":"https://ror.org/00a3bx267","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210090866"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Tani","raw_affiliation_strings":["Department of Virology, Toyama Institute of Health, Toyama, Japan","Department of Virology, Toyama Institute of Health, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Virology, Toyama Institute of Health, Toyama, Japan","institution_ids":["https://openalex.org/I4210090866"]},{"raw_affiliation_string":"Department of Virology, Toyama Institute of Health, Japan","institution_ids":["https://openalex.org/I4210090866"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102279433","display_name":"Yoshihiro Yoshida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Yoshida","raw_affiliation_strings":["Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020096332","display_name":"Hiroshi Yamada","orcid":"https://orcid.org/0000-0001-6678-2701","observed_orcids":["https://orcid.org/0000-0001-6678-2701"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Yamada","raw_affiliation_strings":["Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001879099","display_name":"Yusuke Takegoshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yusuke Takegoshi","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039788766","display_name":"Makito Kaneda","orcid":"https://orcid.org/0009-0004-3156-2716","observed_orcids":["https://orcid.org/0009-0004-3156-2716"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makito Kaneda","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026583233","display_name":"Yushi Murai","orcid":"https://orcid.org/0000-0001-6853-375X","observed_orcids":["https://orcid.org/0000-0001-6853-375X"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yushi Murai","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042393150","display_name":"Kou Kimoto","orcid":"https://orcid.org/0009-0006-3834-8901","observed_orcids":["https://orcid.org/0009-0006-3834-8901"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kou Kimoto","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043376628","display_name":"Hideki Niimi","orcid":"https://orcid.org/0000-0002-6838-5846","observed_orcids":["https://orcid.org/0000-0002-6838-5846"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Niimi","raw_affiliation_strings":["Department of Clinical Laboratory and Molecular Pathology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Laboratory and Molecular Pathology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Laboratory and Molecular Pathology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Laboratory and Molecular Pathology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087903422","display_name":"Yoshihiro Yamamoto","orcid":"https://orcid.org/0000-0003-2088-8724","observed_orcids":["https://orcid.org/0000-0003-2088-8724"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Yamamoto","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan","institution_ids":["https://openalex.org/I42766147"]},{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Japan","institution_ids":["https://openalex.org/I42766147"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5023085962"],"corresponding_institution_ids":["https://openalex.org/I42766147"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":2.4032,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.87981582,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"15","issue":null,"first_page":"1377014","last_page":"1377014"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.040699999779462814,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8479999899864197},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.9710000157356262},{"id":"https://openalex.org/keywords/breakthrough-infection","display_name":"breakthrough infection","score":0.9100000262260437},{"id":"https://openalex.org/keywords/covid-19-pneumonia","display_name":"COVID-19 pneumonia","score":0.925000011920929},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.984000027179718},{"id":"https://openalex.org/keywords/t-follicular-helper-cells","display_name":"T follicular helper cells","score":0.8399999737739563},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9729999899864197},{"id":"https://openalex.org/keywords/vaccination-status","display_name":"vaccination status","score":0.6269999742507935},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.7139999866485596},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.6370916366577148},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6232863664627075},{"id":"https://openalex.org/C187785154","wikidata":"https://www.wikidata.org/wiki/Q5464664","display_name":"Follicular phase","level":2,"score":0.621253490447998},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5609390735626221},{"id":"https://openalex.org/C57194454","wikidata":"https://www.wikidata.org/wiki/Q424211","display_name":"Acute-phase protein","level":3,"score":0.477075457572937},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4471450746059418},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4419684112071991},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.440623939037323},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.42209818959236145},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.42100173234939575},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41595935821533203},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3695543706417084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3277208209037781},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.24007689952850342},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.17823049426078796},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16263458132743835},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.127852201461792},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.07424890995025635}],"mesh":[{"descriptor_ui":"D000084522","descriptor_name":"T Follicular Helper Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000093742","descriptor_name":"Breakthrough Infections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2024.1377014","doi":"https://doi.org/10.3389/fimmu.2024.1377014","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2024.1377014","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1377014/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11061453","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11061453","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11061453/pdf/fimmu-15-1377014.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:38694512","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38694512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d750f7ec821645768008d4c89515a818","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/d750f7ec821645768008d4c89515a818","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 15 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2024.1377014","doi":"https://doi.org/10.3389/fimmu.2024.1377014","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2024.1377014","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1377014/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1251269414","display_name":"\u591a\u69d8\u306a\u611f\u67d3\u75c7\u5371\u6a5f\u306b\u8cc7\u3059\u308b\u52d5\u7269\u30e2\u30c7\u30eb\u89e3\u6790\u30fb\u4eba\u6750\u990a\u6210\u57fa\u76e4\u306e\u958b\u767a","funder_award_id":"21fk0108588h0001","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G3409691586","display_name":"Research using \"bacteria count\" as a biomarker using rapid identification and quantitation method of pathogenic bacteria 4 hours after blood collection","funder_award_id":"23K21403","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G7263737006","display_name":"COVID-19\u30e2\u30c7\u30eb\u3067\u306e\u6ffe\u80de\u6027\u30d8\u30eb\u30d1\u30fcT\u7d30\u80de\u306b\u3088\u308b\u514d\u75ab\u5fdc\u7b54\u4fee\u98fe\u6a5f\u69cb\u306e\u89e3\u660e","funder_award_id":"23K15364","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G7528368445","display_name":"\u9ad8\u75c5\u539f\u6027\u30a6\u30a4\u30eb\u30b9\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306b\u8fc5\u901f\u5bfe\u5fdc\u53ef\u80fd\u306a\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u4e2d\u548c\u6297\u4f53\u691c\u67fb\u6cd5\u306e\u958b\u767a","funder_award_id":"20he0622035h0001","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G85427821","display_name":"Identification of neutralizing activity levels to prevent COVID-19 progression and expansion of vaccination programs","funder_award_id":"22K20768","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320316431","display_name":"University of Toyama","ror":"https://ror.org/0445phv87"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4394888069.pdf","grobid_xml":"https://content.openalex.org/works/W4394888069.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1679550864","https://openalex.org/W2016844693","https://openalex.org/W2946450286","https://openalex.org/W3005789454","https://openalex.org/W3046781741","https://openalex.org/W3049048202","https://openalex.org/W3102432623","https://openalex.org/W3113228067","https://openalex.org/W3120347629","https://openalex.org/W3159073875","https://openalex.org/W3163785571","https://openalex.org/W3175844759","https://openalex.org/W3178981008","https://openalex.org/W3195497784","https://openalex.org/W3196071566","https://openalex.org/W3208597834","https://openalex.org/W3211329889","https://openalex.org/W3215034214","https://openalex.org/W3215827060","https://openalex.org/W3216298236","https://openalex.org/W4200368137","https://openalex.org/W4200439637","https://openalex.org/W4205708037","https://openalex.org/W4206175278","https://openalex.org/W4210308999","https://openalex.org/W4212898080","https://openalex.org/W4213386337","https://openalex.org/W4214863616","https://openalex.org/W4220908383","https://openalex.org/W4223603433","https://openalex.org/W4224249824","https://openalex.org/W4229017905","https://openalex.org/W4285727519","https://openalex.org/W4292553048","https://openalex.org/W4296720230","https://openalex.org/W4309840165","https://openalex.org/W4313454006","https://openalex.org/W4317212025","https://openalex.org/W4319063752","https://openalex.org/W4321611793","https://openalex.org/W4322217276","https://openalex.org/W4323348423","https://openalex.org/W4353020329","https://openalex.org/W4360871696","https://openalex.org/W4386421160"],"related_works":["https://openalex.org/W4380090968","https://openalex.org/W4289597273","https://openalex.org/W4402575007","https://openalex.org/W4385514264","https://openalex.org/W4210790512","https://openalex.org/W4396944095","https://openalex.org/W4289969212","https://openalex.org/W4224252961","https://openalex.org/W4384130742","https://openalex.org/W4389221490"],"abstract_inverted_index":{"Background:":[0],"Acute":[1],"immune":[2],"responses":[3,22],"to":[4],"coronavirus":[5],"disease":[6],"2019":[7],"(COVID-19)":[8],"are":[9],"influenced":[10],"by":[11],"variants,":[12],"vaccination,":[13],"and":[14,27,30,33,59,90,93,123,150,154,202,229],"clinical":[15],"severity.":[16],"Thus,":[17],"the":[18,45,118,129,134,140,148,176,216],"outcome":[19],"of":[20,53,142,169,218],"these":[21,40],"may":[23],"differ":[24],"between":[25,147,195,222],"vaccinated":[26,58,130,149,182,209],"unvaccinated":[28,61,151],"patients":[29,55,111,160,183],"those":[31,132,165,188],"with":[32,44,161,184],"without":[34,166,189],"COVID-19-related":[35],"pneumonia.":[36],"In":[37],"this":[38,76],"study,":[39],"differences":[41],"during":[42],"infection":[43],"Omicron":[46,135,177,233],"variant":[47,136,178],"were":[48,64,73,95,104,126,145,157,179],"investigated.":[49],"Methods:":[50],"A":[51],"total":[52],"67":[54],"(including":[56],"47":[57],"20":[60],"patients)":[62],"who":[63],"hospitalized":[65],"within":[66],"5":[67],"days":[68],"after":[69],"COVID-19":[70,113],"symptom":[71],"onset":[72],"enrolled":[74],"in":[75,128,159,164,181,187,208,232],"prospective":[77],"observational":[78],"study.":[79],"Serum":[80],"neutralizing":[81,119,196,223],"activity":[82,174,197,224],"was":[83,205],"evaluated":[84,105],"using":[85,106],"a":[86,192,219],"pseudotyped":[87],"virus":[88],"assay":[89],"serum":[91],"cytokines":[92],"chemokines":[94],"measured.":[96],"Circulating":[97],"follicular":[98],"helper":[99],"T":[100],"cell":[101],"(cTfh)":[102],"frequencies":[103],"flow":[107],"cytometry.":[108],"Results:":[109],"Twenty-five":[110],"developed":[112],"pneumonia":[114,144,162,185],"on":[115],"hospitalization.":[116],"Although":[117],"activities":[120],"against":[121,133,175,198,225],"wild-type":[122],"Delta":[124],"variants":[125],"higher":[127,158,180],"group,":[131],"as":[137,139],"well":[138],"frequency":[141],"developing":[143],"comparable":[146],"groups.":[152],"IL-6":[153,200,227],"CXCL10":[155],"levels":[156],"than":[163,186],"it,":[167],"regardless":[168],"their":[170],"vaccination":[171],"status.":[172],"Neutralizing":[173],"it.":[190],"Moreover,":[191],"distinctive":[193],"correlation":[194],"Omicron,":[199,226],"levels,":[201,228],"cTfh":[203,230],"proportions":[204,231],"observed":[206],"only":[207],"patients.":[210],"Conclusions:":[211],"The":[212],"present":[213],"study":[214],"demonstrates":[215],"existence":[217],"characteristic":[220],"relationship":[221],"breakthrough":[234],"infection.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-04-18T00:00:00"}